These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Continuous T-wave alternans monitoring to predict impending life-threatening cardiac arrhythmias during emergent coronary reperfusion therapy in patients with acute coronary syndrome. Takasugi N, Kubota T, Nishigaki K, Verrier RL, Kawasaki M, Takasugi M, Ushikoshi H, Hattori A, Ojio S, Aoyama T, Takemura G, Minatoguchi S. Europace; 2011 May; 13(5):708-15. PubMed ID: 21317426 [Abstract] [Full Text] [Related]
25. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction. Pride YB, Appelbaum E, Lord EE, Sloan S, Cannon CP, Sabatine MS, Gibson CM, TIMI Study Group. Am J Cardiol; 2009 Aug 15; 104(4):475-9. PubMed ID: 19660597 [Abstract] [Full Text] [Related]
26. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype. Letsas KP, Weber R, Astheimer K, Kalusche D, Arentz T. Europace; 2010 Feb 15; 12(2):271-4. PubMed ID: 19897501 [Abstract] [Full Text] [Related]
27. Outcome of contemporary acute coronary syndrome complicated by ventricular tachyarrhythmias. Orvin K, Eisen A, Goldenberg I, Gottlieb S, Kornowski R, Matetzky S, Golovchiner G, Kuznietz J, Gavrielov-Yusim N, Segev A, Strasberg B, Haim M. Europace; 2016 Feb 15; 18(2):219-26. PubMed ID: 25840284 [Abstract] [Full Text] [Related]
28. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome. Chyrchel M, Rakowski T, Rzeszutko L, Legutko J, Dziewierz A, Dubiel JS, Dudek D. Kardiol Pol; 2006 Dec 15; 64(12):1357-62; discussion 1363. PubMed ID: 17206539 [Abstract] [Full Text] [Related]
32. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study. Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, Muller JE, Albert CM, TOVA Investigators. Circulation; 2004 Mar 23; 109(11):1386-91. PubMed ID: 14993132 [Abstract] [Full Text] [Related]
33. Protective effects of acidic fibroblast growth factor against cardiac arrhythmias induced by ischemia and reperfusion in rats. Cuevas P, Carceller F, Hernández-Madrid A, Cuevas B, Martínez-Coso V, Giménez-Gallego G. Eur J Med Res; 1997 Jan 23; 2(1):33-6. PubMed ID: 9049592 [Abstract] [Full Text] [Related]
38. The changing incidence of ventricular fibrillation in Milwaukee, Wisconsin (1992-2002). Polentini MS, Pirrallo RG, McGill W. Prehosp Emerg Care; 2006 Jan 23; 10(1):52-60. PubMed ID: 16418092 [Abstract] [Full Text] [Related]
39. Prior statin use and the incidence of in-hospital arrhythmia in acute coronary syndrome: A systematic review and meta-analysis. Wibawa K, Dewangga R, Nastiti KS, Syah PA, Suhendiwijaya S, Ariffudin Y. Indian Heart J; 2023 Jan 23; 75(1):9-16. PubMed ID: 36642406 [Abstract] [Full Text] [Related]
40. Anti-arrhythmic effects of statins: a hypothesis remains to be tested. Guo HM. Heart Rhythm; 2008 Apr 23; 5(4):511-2. PubMed ID: 18362017 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]